111 related articles for article (PubMed ID: 2417781)
1. Immunoelectrophoretic analysis of C4 split products expressing D but not C epitopes: influence of storage, Ca2+ and Ca2+-chelating agents.
Petersen NE; Folkersen J; Teisner B; Svehag SE
Complement; 1985; 2(2-3):147-55. PubMed ID: 2417781
[TBL] [Abstract][Full Text] [Related]
2. Preparation of antibodies against the fourth complement component (C4) and development of a direct electroimmunoassay for quantification of C4d.
Folkersen J; Teisner B; Petersen NE; Sim RB; Jessen E
J Clin Lab Immunol; 1985 Mar; 16(3):163-7. PubMed ID: 4032454
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of C4d and C3d and their complex formation with serum albumin.
Petersen NE; Teisner B; Folkersen J; Svehag SE
Acta Pathol Microbiol Immunol Scand C; 1987 Aug; 95(4):129-35. PubMed ID: 3499750
[TBL] [Abstract][Full Text] [Related]
4. Rocket immunoelectrophoresis of C4 and C4d. A simple sensitive method for detecting complement activation in plasma.
Nitsche JF; Tucker ES; Sugimoto S; Vaughan JH; Curd JG
Am J Clin Pathol; 1981 Nov; 76(5):679-84. PubMed ID: 6794354
[TBL] [Abstract][Full Text] [Related]
5. Influence of time, temperature and coagulation on the measurement of C3, C3 split products and C4.
Sinosich MJ; Teisner B; Brandslund I; Fisher M; Grudzinskas JG
J Immunol Methods; 1982 Nov; 55(1):107-14. PubMed ID: 6818279
[TBL] [Abstract][Full Text] [Related]
6. Clinical application of new technique that measures C4d for assessment of activation of classical complement pathway.
Davies ET; Nasaruddin BA; Alhaq A; Senaldi G; Vergani D
J Clin Pathol; 1988 Feb; 41(2):143-7. PubMed ID: 3350977
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.
Taillon-Miller PA; Shreffler DC
J Immunol; 1988 Oct; 141(7):2382-7. PubMed ID: 2459207
[TBL] [Abstract][Full Text] [Related]
9. Capillary C4d deposition as a marker of humoral immunity in renal allograft rejection.
Watschinger B; Pascual M
J Am Soc Nephrol; 2002 Sep; 13(9):2420-3. PubMed ID: 12191988
[No Abstract] [Full Text] [Related]
10. Antigenic determinants of human C4, Rodgers and Chido.
Giles CM
Exp Clin Immunogenet; 1988; 5(2-3):99-114. PubMed ID: 2483343
[TBL] [Abstract][Full Text] [Related]
11. [In-vivo activation of the 4th component of the complement system (C4) in premature and term infants with generalized bacterial infections].
Nürnberger W; Stannigel H; Müntel V; Michelmann I; Wahn V; Göbel U
Klin Padiatr; 1990; 202(3):141-6. PubMed ID: 2355716
[TBL] [Abstract][Full Text] [Related]
12. Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.
Senaldi G; Makinde VA; Vergani D; Isenberg DA
Ann Rheum Dis; 1988 Nov; 47(11):913-7. PubMed ID: 3264693
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro binding of C4 molecules on red cells: a correlation of numbers of molecules and agglutination.
Giles CM; Davies KA; Walport MJ
Transfusion; 1991; 31(3):222-8. PubMed ID: 1706118
[TBL] [Abstract][Full Text] [Related]
14. Two monoclonal anti-C4d reagents react with epitopes closely related to Rg:1 and Ch:1.
Giles CM; Fielder AH; Lord DK; Robson T; O'Neill GJ
Immunogenetics; 1987; 26(4-5):309-12. PubMed ID: 2443448
[No Abstract] [Full Text] [Related]
15. Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4.
Chakravarti DN; Campbell RD; Gagnon J
FEBS Lett; 1983 Apr; 154(2):387-90. PubMed ID: 6832377
[TBL] [Abstract][Full Text] [Related]
16. Conversion of the C4d.2 serologic allotype of murine complement component C4 to the C4d.1 allotype by site-specific mutagenesis.
Mathias P; Shreffler DC; Cooper NR; Ogata RT
J Immunol; 1990 Jan; 144(2):607-9. PubMed ID: 2295802
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the activation pathways of the complement in psoriatic patients by use of complement fragment C4d and Bb measurements.
Takematsu H; Tagami H
Dermatologica; 1989; 179 Suppl 1():16-9. PubMed ID: 2789155
[TBL] [Abstract][Full Text] [Related]
18. Complement activation by cellulosic dialysis membranes.
Innes A; Farrell AM; Burden RP; Morgan AG; Powell RJ
J Clin Pathol; 1994 Feb; 47(2):155-8. PubMed ID: 8132830
[TBL] [Abstract][Full Text] [Related]
19. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
[TBL] [Abstract][Full Text] [Related]
20. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies.
Behr TM; Feucht HE; Richter K; Reiter C; Spes CH; Pongratz D; Uberfuhr P; Meiser B; Theisen K; Angermann CE
J Heart Lung Transplant; 1999 Sep; 18(9):904-12. PubMed ID: 10528753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
